Literature DB >> 11202235

Elevation of transforming growth factor-beta1 is associated with recurrent miscarriage.

M S Ogasawara1, K Aoki, T Aoyama, K Katano, Y Iinuma, Y Ozaki, K Suzumori.   

Abstract

To investigate the significance of transforming growth factor-beta1 (TGF-beta1) in reproduction we have compared plasma levels in normal pregnant women and patients suffering miscarriages. We examined 188 normal pregnant women and 12 pregnant women with miscarriages. Eight women with severe recurrent miscarriages (mean +/- SD of previous number of miscarriages; 10.4 +/- 2.4 times) were also examined before conception; 34 nonpregnant women served as controls. Plasma TGF-beta1 level increased with the gestational week and returned within the normal range 1 month after delivery. The levels among pregnant women with miscarriages (mean +/- SD; 2.44 +/- 0.83 ng/ml) were significantly higher than those of pregnant controls (1.74 +/- 0.95 ng/ml) of matched gestational weeks; levels among nonpregnant women with severe recurrent miscarriages were extremely elevated (4.1 +/- 3.04 ng/ml) compared to the control value (1.34 +/- 0.59 ng/ml). These data suggest that TGF-beta1 may be necessary to maintain pregnancy but also may be a risk factor for recurrent miscarriages.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11202235     DOI: 10.1023/a:1026459800016

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  21 in total

1.  Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGF-beta, IGF-II, and IGFBP-1.

Authors:  J A Irving; P K Lala
Journal:  Exp Cell Res       Date:  1995-04       Impact factor: 3.905

2.  Transforming growth factor beta 1 inhibits placental differentiation and human chorionic gonadotropin and human placental lactogen secretion.

Authors:  D W Morrish; D Bhardwaj; M T Paras
Journal:  Endocrinology       Date:  1991-07       Impact factor: 4.736

Review 3.  Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?

Authors:  T G Wegmann; H Lin; L Guilbert; T R Mosmann
Journal:  Immunol Today       Date:  1993-07

4.  Interleukin-1 beta, human leukocyte antigen HLA-DR alpha, and transforming growth factor-beta expression in endometrium, placenta, and placental membranes.

Authors:  S Kauma; D Matt; S Strom; D Eierman; T Turner
Journal:  Am J Obstet Gynecol       Date:  1990-11       Impact factor: 8.661

5.  Activin-A stimulates, while transforming growth factor beta 1 inhibits, chorionic gonadotrophin production and aromatase activity in cultured human placental trophoblasts.

Authors:  Y Song; J Keelan; J T France
Journal:  Placenta       Date:  1996-11       Impact factor: 3.481

6.  Opposing actions of transforming growth factor-beta and glucocorticoids in the regulation of fibronectin expression in the human placenta.

Authors:  S Guller; R Wozniak; L Kong; C J Lockwood
Journal:  J Clin Endocrinol Metab       Date:  1995-11       Impact factor: 5.958

7.  Anti-inflammatory effects of interleukin-4, interleukin-10, and transforming growth factor-beta on human placental cells in vitro.

Authors:  V J Goodwin; T A Sato; M D Mitchell; J A Keelan
Journal:  Am J Reprod Immunol       Date:  1998-11       Impact factor: 3.886

8.  Human placenta constitutively produces interleukin-8 during pregnancy and enhances its production in intrauterine infection.

Authors:  K Shimoya; N Matsuzaki; T Taniguchi; T Kameda; M Koyama; R Neki; F Saji; O Tanizawa
Journal:  Biol Reprod       Date:  1992-08       Impact factor: 4.285

9.  Regulation of NK cell functions by TGF-beta 1.

Authors:  G Bellone; M Aste-Amezaga; G Trinchieri; U Rodeck
Journal:  J Immunol       Date:  1995-08-01       Impact factor: 5.422

10.  Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10.

Authors:  I Roth; D B Corry; R M Locksley; J S Abrams; M J Litton; S J Fisher
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

View more
  6 in total

1.  Exercise-induced changes in circulating levels of transforming growth factor-beta-1 in humans: methodological considerations.

Authors:  Katja Heinemeier; Henning Langberg; Michael Kjaer
Journal:  Eur J Appl Physiol       Date:  2003-07-09       Impact factor: 3.078

2.  Evaluation of Th17 and Treg cytokines in patients with unexplained recurrent pregnancy loss.

Authors:  Maral Farshchi; Elham Abdollahi; Nafiseh Saghafi; Ahmad Hosseini; Sara Fallahi; Sirus Rostami; Parifar Rostami; Houshang Rafatpanah; Mojtaba Habibagahi
Journal:  J Clin Transl Res       Date:  2022-05-25

Review 3.  Angiogenesis in implantation.

Authors:  Donald S Torry; Jonathan Leavenworth; Miao Chang; Vatsala Maheshwari; Kathleen Groesch; Evan R Ball; Ronald J Torry
Journal:  J Assist Reprod Genet       Date:  2007-07       Impact factor: 3.412

4.  The Role of Interleukin-17, Interleukin-23, and Transforming Growth Factor-β in Pregnancy Complicated by Placental Insufficiency.

Authors:  Dorota Darmochwal-Kolarz; Magdalena Michalak; Bogdan Kolarz; Monika Przegalinska-Kalamucka; Agnieszka Bojarska-Junak; Dariusz Sliwa; Jan Oleszczuk
Journal:  Biomed Res Int       Date:  2017-06-15       Impact factor: 3.411

5.  Androgen-induced alterations in endometrial proteins crucial in recurrent miscarriages.

Authors:  Tanzil Ur Rahman; Kamran Ullah; Meng-Xi Guo; Hai-Tao Pan; Juan Liu; Jun Ren; Lu-Yang Jin; Yu-Zhong Zhou; Yi Cheng; Jian-Zhong Sheng; He-Feng Huang
Journal:  Oncotarget       Date:  2018-05-15

6.  The role of mediating factors involved in angiogenesis during implantation.

Authors:  Lidia Boldeanu; Anda Lorena Dijmărescu; Mirela Radu; Cristian Adrian Siloşi; Mircea Vasile Popescu-Drigă; Ioan Sabin Poenariu; Isabela Siloşi; Mihail Virgil Boldeanu; Marius Bogdan Novac; Liliana Victoria Novac
Journal:  Rom J Morphol Embryol       Date:  2020 Jul-Sep       Impact factor: 1.033

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.